Evidence map›Paper›PMID 38357285›Full record

ArticleACS pharmacology & translational science2024

Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats.

Daihyun Song, Bethany Crouse, Jennifer Vigliaturo, Mariah M Wu, Dagny Heimisdottir, Andrew J Kassick, Saadyah E Averick, Michael D Raleigh, Marco Pravetoni

Open access · greenAbstract read
In one paragraph

Article in ACS pharmacology & translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Daihyun SongDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.ORCID https://orcid.org/0009-0008-5193-0861
Bethany CrouseDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.ORCID https://orcid.org/0000-0002-1984-2465
Jennifer VigliaturoDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
Mariah M WuDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
Dagny HeimisdottirDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
Andrew J KassickNeuroscience Disruptive Research Lab, Allegheny Health Network Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, United States.
Saadyah E AverickNeuroscience Disruptive Research Lab, Allegheny Health Network Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, United States.
Michael D RaleighDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
Marco PravetoniDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
University of Minnesota Medical Center · USAllegheny Health Network · USUniversity of Minnesota · USUniversity of Washington · US

Funding

Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdoseUH3DA048386 · NIDA · UNIVERSITY OF WASHINGTON · PI PRAVETONI, MARCO · 2022 to 2024
$11.0M
Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdoseUG3DA048386 · NIDA · UNIVERSITY OF MINNESOTA · PI PRAVETONI, MARCO · 2019 to 2020
$3.3M
Identifying mechanisms and biomarkers predictive of individual variability in efficacy of vaccines against opioid use disorderF31DA054760 · NIDA · UNIVERSITY OF MINNESOTA · PI CROUSE, BETHANY K · 2021 to 2021
$27k
NIDA NIH HHS F31 DA054760NIDA NIH HHS UG3 DA048386NIDA NIH HHS UH3 DA048386
6 · The paper itself

Abstract

Illicit drug mixtures containing opioids and stimulants have been responsible for the majority of fatal drug overdoses among occasional users, and those with either opioid use disorder (OUD) or substance use disorder (SUD). As a complementary strategy to current pharmacotherapies, active immunization with conjugate vaccines has been proposed as a viable intervention to treat OUD as well as other SUD for which there are either limited or no treatment options. Vaccination against opioids and stimulants could help address the limitations of current medications (e.g., patient access, compliance, misuse liability, and safety) by providing an additional tool to prevent drug misuse and/or overdoses. However, more research is needed to fully understand the potential benefits and limitations of using vaccines to treat SUD and overdose and to inform us on how to deploy this strategy in the field. Previous reports have shown promise by combining two vaccines into bivalent vaccine formulations to concurrently target multiple drugs. Here, multiple individual candidate monovalent vaccines were incrementally combined in multivalent vaccine formulations to simultaneously target fentanyl, carfentanil, oxycodone, heroin, methamphetamine, and their analogs or metabolites. Bi-, tri-, and quadrivalent vaccine formulations induced the formation of independent serum antibody responses against their respective opioid targets and selectively attenuated the distribution of each individual drug to the brain in mice and rats. Results indicate that a single injection of an admixed multivalent vaccine formulation may be more effective than coinjecting multiple monovalent vaccines at multiple sites. Finally, adding a methamphetamine conjugate vaccine to an quadrivalent opioid vaccine in a pentavalent formulation did not interfere with the production of effective antiopioid IgG antibodies. Multivalent vaccines could provide multifaceted, yet selective, protection against polydrug use and exposure.

Identifiers

PMID38357285
PMCPMC10863445
OpenAlexW4390114801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.